AI-driven diversity goals are reshaping clinical supply. Better data means more sites, more cross-border shipments, and new forecasting challenges for global trials.
- Managing Inbound Supply Risk With R3M In Clinical Supply Chains
- Export Control Risks Hidden In Clinical Supply Workflows
- The Post-American Supply Chain: Navigating The New Multipolar Clinical Landscape
- Building Resilient Clinical Supply Chains In An Era Of Global Disruption
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 3 – Staying Aligned in a Moving System
- Forecast Vs. Actual: Why Protocol Design Breaks Clinical Supply Plans
- AI In Clinical Trial Supply Chains
- Clinical Trial Supply Lessons From Ebola Outbreak Response
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Flexible Integrations To Reduce Risks And Increase Efficiencies
Learn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.
-
What Is Interactive Response Technology (IRT)?
Learn how protocol-driven IRT systems support supply management and randomization to help trial teams cut risk and costs.
-
GxP Inventory Solution Improves Clinical IP Efficiency And Compliance
Learn how this biopharmaceutical research sponsor was able to centralize and digitalize the processes involved in clinical supply production through distribution using GxP Inventory.
-
The Critical Role Of Clinical Trial Packaging Services In Trial Success
Compliant, accurate packaging protects product integrity, supports dosing consistency, and keeps studies running smoothly. Smart components and controlled processes lower risk across complex trials.
-
Modern Architecture's Impact On UX In Next-Gen Interactive Response Tech
Explore how Interactive Response Technologies (IRTs) built around microservices models can provide faster initial builds, more rapid change management, and improved built-in test automation.
-
Powering Complex Personalized Medicine Oncology Trial
Managing custom therapies requires a synchronized supply chain. Learn how to bridge the gap between manufacturing and clinical workflows to ensure seamless patient care in complex oncology trials.
-
Optimizing IRT For Clinical Supply Management
Experts speak on supply capabilities within interactive response technology (IRT) – how flexibility is important to functionality and who to involve and which questions to ask in optimizing IRT for clinical supply.
-
Navigate Complex Ancillary Supply Sourcing Challenges
Explore the evolvement of the clinical trial landscape over recent years, as well as the new challenges that this poses for the clinical supply chain.
-
Benefits Of Electronic Labels: Investigational Medicinal Products
When a new therapeutic drug, medical device, vaccine, or other investigational medicinal product (IMP) is developed, learn why a label must be on its packaging that provides relevant and important information.
-
A Supply Chain Management Solution Designed for Clinical Research
In this use case, follow along the clinical supplies management journey to learn how GxP Inventory replaces fragmented, spreadsheet-based processes to optimize visibility, traceability, and compliance.
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 3 – Staying Aligned in a Moving System
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 2 – Where Assumptions Break Trials
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 1 – The Cost Of Late Involvement
- From Invisible to Integral: Inviting Clinical Supply Expertise to the Planning Table
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.